Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "GE"

9918 News Found

India reaffirms commitment to global women and child health agenda at WHA 2026
Policy | May 21, 2026

India reaffirms commitment to global women and child health agenda at WHA 2026

Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva


National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform
R&D | May 21, 2026

National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform

NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro


Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
R&D | May 21, 2026

Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration

This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access


Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal
Hospitals | May 21, 2026

Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal

Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India


Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data
Clinical Trials | May 21, 2026

Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data

Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials


Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates
News | May 20, 2026

Regeneron signs $2.32 billion deal with Parabilis for Helicon conjugates

The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform


Gleneagles hospital performs customised 3D-printed hip reconstruction surgery
Hospitals | May 20, 2026

Gleneagles hospital performs customised 3D-printed hip reconstruction surgery

A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern


Lupin gets tentative FDA nod for Revefenacin inhalation solution
Drug Approval | May 20, 2026

Lupin gets tentative FDA nod for Revefenacin inhalation solution

The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)


Shaily gets regulatory nod for launch of ShailyPen Neo device technology
Medical Device | May 20, 2026

Shaily gets regulatory nod for launch of ShailyPen Neo device technology

The product has received tentative USFDA approval, Health Canada notice of compliance, and Indian regulatory approval


IGI’s new drug candidate ISB 2301 to target solid tumors
Biopharma | May 20, 2026

IGI’s new drug candidate ISB 2301 to target solid tumors

The company intends to file an IND submission by the end of this year and begin clinical studies in 2027